Inventor
ROSSI KAREN A
US25 patents
⚠️ This page may combine multiple inventors who share the name “ROSSI KAREN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
13 patentsUS7453002B2Nov 18, 2008
Five-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO24 citations92
US10487086B2Nov 26, 2019
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US9802939B2Oct 31, 2017
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US7928230B2Apr 19, 2011
Method for modulating GPR119 G protein-coupled receptor and selected compounds
BRISTOL MYERS SQUIBB CO10 citations84
US11136327B2Oct 5, 2021
Macrocycles as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO1 citations73
US8372837B2Feb 12, 2013
Pyridone and pyridazone analogues as GPR119 modulators
BRISTOL MYERS SQUIBB CO3 citations63
US8003796B2Aug 23, 2011
Pyridone GPR119 G protein-coupled receptor agonists
BRISTOL MYERS SQUIBB CO3 citations63
US12404274B2Sep 2, 2025
Macrocycles as factor xia inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US10112936B2Oct 30, 2018
Five-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9617224B2Apr 11, 2017
Five-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9079860B2Jul 14, 2015
Five-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US11180490B2Nov 23, 2021
Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
BRISTOL MYERS SQUIBB CO0 citations50
US7381732B2Jun 3, 2008
Pyrazolobenzamides and derivatives as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO1 citations49
BRISTOL MYERS SQUIBB PHARMA CO
4 patentsUS6548525B2Apr 15, 2003
Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO125 citations96
US6413980B1Jul 2, 2002
Nitrogen containing heterobicycles as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO41 citations92
US6552042B2Apr 22, 2003
Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa
BRISTOL MYERS SQUIBB PHARMA CO20 citations91
US6858616B2Feb 22, 2005
Nitrogen containing heterobicycles as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO4 citations62
WACKER DEAN A
3 patentsUS8232404B2Jul 31, 2012
Pyridone GPR119 G protein-coupled receptor agonists
WACKER DEAN A2 citations60
US8513424B2Aug 20, 2013
Pyridone GPR119 G protein-coupled receptor agonists
WACKER DEAN A0 citations50
US8178561B2May 15, 2012
Method for modulating GPR119 G protein-coupled receptor and selected compounds
WACKER DEAN A0 citations50
DU PONT PHARM CO
2 patentsUS6271237B1Aug 7, 2001
Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors
DU PONT PHARM CO57 citations94
US6207697B1Mar 27, 2001
Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa
DU PONT PHARM CO73 citations94